肿瘤研究所报告第四季度结果

2025-03-27 23:27

The Oncology Institute press release (NASDAQ:TOI): Q4 revenue of $100 million, an increase of 16.9% compared to the prior year quarter.
Gross profit of $15 million, an increase of 1.8% compared to the prior year quarter.
Basic and diluted loss per share of $(0.14) and $(0.14), respectively, compared to $(0.21) and $(0.21) for the prior year quarter.
Adjusted EBITDA of $(7.8) million compared to $(6.3) million for the prior year quarter.
Cash, cash equivalents, and investments of $50 million as of December 31, 2024.

More on The Oncology Institute